6 Analysts Have This To Say About Encompass Health
Portfolio Pulse from Benzinga Insights
Six analysts have provided varied opinions on Encompass Health (NYSE:EHC) over the past quarter, with ratings ranging from bullish to somewhat bullish. The average 12-month price target has increased by 7.41% to $98.17. Analysts from RBC Capital, Raymond James, Barclays, and Mizuho have raised their price targets and ratings for EHC. The company has shown strong financial health with significant revenue growth, high net margins, and effective debt management.
May 22, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have shown increased confidence in Encompass Health (NYSE:EHC), raising their price targets and ratings. The average 12-month price target has risen by 7.41% to $98.17, reflecting positive sentiment. The company's strong financial performance, including significant revenue growth and effective debt management, supports this bullish outlook.
The increase in average price target and positive ratings from multiple analysts indicate a strong bullish sentiment. Encompass Health's robust financial performance, including high revenue growth and effective debt management, further supports the positive outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100